LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models.

    Tosh, Justin L / Rhymes, Elena R / Mumford, Paige / Whittaker, Heather T / Pulford, Laura J / Noy, Sue J / Cleverley, Karen / Walker, Matthew C / Tybulewicz, Victor L J / Wykes, Rob C / Fisher, Elizabeth M C / Wiseman, Frances K

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 5736

    Abstract: Individuals who have Down syndrome (caused by trisomy of chromosome 21), have a greatly elevated risk of early-onset Alzheimer's disease, in which amyloid-β accumulates in the brain. Amyloid-β is a product of the chromosome 21 gene APP (amyloid precursor ...

    Abstract Individuals who have Down syndrome (caused by trisomy of chromosome 21), have a greatly elevated risk of early-onset Alzheimer's disease, in which amyloid-β accumulates in the brain. Amyloid-β is a product of the chromosome 21 gene APP (amyloid precursor protein) and the extra copy or 'dose' of APP is thought to be the cause of this early-onset Alzheimer's disease. However, other chromosome 21 genes likely modulate disease when in three-copies in people with Down syndrome. Here we show that an extra copy of chromosome 21 genes, other than APP, influences APP/Aβ biology. We crossed Down syndrome mouse models with partial trisomies, to an APP transgenic model and found that extra copies of subgroups of chromosome 21 gene(s) modulate amyloid-β aggregation and APP transgene-associated mortality, independently of changing amyloid precursor protein abundance. Thus, genes on chromosome 21, other than APP, likely modulate Alzheimer's disease in people who have Down syndrome.
    MeSH term(s) Alzheimer Disease/complications ; Alzheimer Disease/genetics ; Amyloid beta-Peptides/chemistry ; Amyloid beta-Peptides/genetics ; Amyloid beta-Protein Precursor/genetics ; Animals ; Brain/pathology ; Chromosomes, Mammalian/genetics ; Disease Models, Animal ; Down Syndrome/complications ; Down Syndrome/genetics ; Mice ; Mice, Transgenic ; Phenotype ; Phosphotransferases/metabolism ; Protein Aggregates ; Protein-Arginine N-Methyltransferases/metabolism ; Segmental Duplications, Genomic ; Seizures/complications ; Seizures/pathology ; Solubility ; Survival Analysis ; Transgenes
    Chemical Substances Amyloid beta-Peptides ; Amyloid beta-Protein Precursor ; Protein Aggregates ; PRMT2 protein, mouse (EC 2.1.1.319) ; Protein-Arginine N-Methyltransferases (EC 2.1.1.319) ; Pdxk protein, mouse (EC 2.7.-) ; Phosphotransferases (EC 2.7.-)
    Language English
    Publishing date 2021-03-11
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-85062-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Publisher Correction: Genetic dissection of down syndrome‑associated alterations in APP/amyloid‑β biology using mouse models.

    Tosh, Justin L / Rhymes, Elena R / Mumford, Paige / Whittaker, Heather T / Pulford, Laura J / Noy, Sue J / Cleverley, Karen / Walker, Matthew C / Tybulewicz, Victor L J / Wykes, Rob C / Fisher, Elizabeth M C / Wiseman, Frances K

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 14966

    Language English
    Publishing date 2021-07-16
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-94313-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Dissecting Alzheimer disease in Down syndrome using mouse models.

    Choong, Xun Yu / Tosh, Justin L / Pulford, Laura J / Fisher, Elizabeth M C

    Frontiers in behavioral neuroscience

    2015  Volume 9, Page(s) 268

    Abstract: Down syndrome (DS) is a common genetic condition caused by the presence of three copies of chromosome 21 (trisomy 21). This greatly increases the risk of Alzheimer disease (AD), but although virtually all people with DS have AD neuropathology by 40 years ...

    Abstract Down syndrome (DS) is a common genetic condition caused by the presence of three copies of chromosome 21 (trisomy 21). This greatly increases the risk of Alzheimer disease (AD), but although virtually all people with DS have AD neuropathology by 40 years of age, not all develop dementia. To dissect the genetic contribution of trisomy 21 to DS phenotypes including those relevant to AD, a range of DS mouse models has been generated which are trisomic for chromosome segments syntenic to human chromosome 21. Here, we consider key characteristics of human AD in DS (AD-DS), and our current state of knowledge on related phenotypes in AD and DS mouse models. We go on to review important features needed in future models of AD-DS, to understand this type of dementia and so highlight pathogenic mechanisms relevant to all populations at risk of AD.
    Language English
    Publishing date 2015-10-13
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2452960-6
    ISSN 1662-5153
    ISSN 1662-5153
    DOI 10.3389/fnbeh.2015.00268
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The integration site of the

    Tosh, Justin L / Rickman, Matthew / Rhymes, Ellie / Norona, Frances E / Clayton, Emma / Mucke, Lennart / Isaacs, Adrian M / Fisher, Elizabeth M C / Wiseman, Frances K

    Wellcome open research

    2018  Volume 2, Page(s) 84

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2018-10-10
    Publishing country England
    Document type Journal Article
    ISSN 2398-502X
    ISSN 2398-502X
    DOI 10.12688/wellcomeopenres.12237.2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP.

    Wiseman, Frances K / Pulford, Laura J / Barkus, Chris / Liao, Fan / Portelius, Erik / Webb, Robin / Chávez-Gutiérrez, Lucia / Cleverley, Karen / Noy, Sue / Sheppard, Olivia / Collins, Toby / Powell, Caroline / Sarell, Claire J / Rickman, Matthew / Choong, Xun / Tosh, Justin L / Siganporia, Carlos / Whittaker, Heather T / Stewart, Floy /
    Szaruga, Maria / Murphy, Michael P / Blennow, Kaj / de Strooper, Bart / Zetterberg, Henrik / Bannerman, David / Holtzman, David M / Tybulewicz, Victor L J / Fisher, Elizabeth M C

    Brain : a journal of neurology

    2018  Volume 141, Issue 8, Page(s) 2457–2474

    Abstract: Down syndrome, caused by trisomy of chromosome 21, is the single most common risk factor for early-onset Alzheimer's disease. Worldwide approximately 6 million people have Down syndrome, and all these individuals will develop the hallmark amyloid plaques ...

    Abstract Down syndrome, caused by trisomy of chromosome 21, is the single most common risk factor for early-onset Alzheimer's disease. Worldwide approximately 6 million people have Down syndrome, and all these individuals will develop the hallmark amyloid plaques and neurofibrillary tangles of Alzheimer's disease by the age of 40 and the vast majority will go on to develop dementia. Triplication of APP, a gene on chromosome 21, is sufficient to cause early-onset Alzheimer's disease in the absence of Down syndrome. However, whether triplication of other chromosome 21 genes influences disease pathogenesis in the context of Down syndrome is unclear. Here we show, in a mouse model, that triplication of chromosome 21 genes other than APP increases amyloid-β aggregation, deposition of amyloid-β plaques and worsens associated cognitive deficits. This indicates that triplication of chromosome 21 genes other than APP is likely to have an important role to play in Alzheimer's disease pathogenesis in individuals who have Down syndrome. We go on to show that the effect of trisomy of chromosome 21 on amyloid-β aggregation correlates with an unexpected shift in soluble amyloid-β 40/42 ratio. This alteration in amyloid-β isoform ratio occurs independently of a change in the carboxypeptidase activity of the γ-secretase complex, which cleaves the peptide from APP, or the rate of extracellular clearance of amyloid-β. These new mechanistic insights into the role of triplication of genes on chromosome 21, other than APP, in the development of Alzheimer's disease in individuals who have Down syndrome may have implications for the treatment of this common cause of neurodegeneration.
    MeSH term(s) Alzheimer Disease/pathology ; Amyloid beta-Peptides/metabolism ; Amyloid beta-Protein Precursor/genetics ; Amyloid beta-Protein Precursor/physiology ; Animals ; Brain/pathology ; Disease Models, Animal ; Down Syndrome/genetics ; Down Syndrome/pathology ; Female ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Neurofibrillary Tangles/pathology ; Plaque, Amyloid/genetics ; Plaque, Amyloid/pathology ; Trisomy
    Chemical Substances APP protein, human ; Amyloid beta-Peptides ; Amyloid beta-Protein Precursor
    Language English
    Publishing date 2018-06-27
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80072-7
    ISSN 1460-2156 ; 0006-8950
    ISSN (online) 1460-2156
    ISSN 0006-8950
    DOI 10.1093/brain/awy159
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top